In the US, Risperdal (risperidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Asperger Syndrome, Autism, Bipolar Disorder, Borderline Personality Disorder, Depression, Head Injury, Mania, Nightmares, Paranoid Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder, Schizophrenia, Social Anxiety Disorder and Tardive Dyskinesia.
US matches:
- Risperdal
- Risperdal Consta
- Risperdal M-Tab Orally Disintegrating Tablets
- Risperdal Solution
- Risperdal M-Tab
UK matches:
- RISPERDAL CONSTA 25, 37.5 and 50 mg powder and solvent for prolonged-release suspension for intramuscular injection (SPC)
- Risperdal Tablets, Liquid & Quicklet (SPC)
Ingredient matches for Risperdal
Risperidone
Risperidone is reported as an ingredient of Risperdal in the following countries:
- Algeria
- Antigua & Barbuda
- Argentina
- Aruba
- Australia
- Austria
- Bahamas
- Bangladesh
- Barbados
- Belgium
- Bermuda
- Brazil
- Canada
- Cayman Islands
- Chile
- China
- Colombia
- Costa Rica
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Finland
- France
- Germany
- Greece
- Grenada
- Guatemala
- Guyana
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Lebanon
- Luxembourg
- Malaysia
- Malta
- Mexico
- Netherlands
- Netherlands Antilles
- New Zealand
- Nicaragua
- Norway
- Oman
- Panama
- Peru
- Philippines
- Portugal
- Saint Lucia
- Saint Vincent & The Grenadines
- Saudi Arabia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sri Lanka
- Sudan
- Suriname
- Sweden
- Switzerland
- Taiwan
- Thailand
- Trinidad & Tobago
- Tunisia
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Yemen
Risperidone tartrate (a derivative of Risperidone) is reported as an ingredient of Risperdal in the following countries:
- Canada
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment